Adaptive Biotechnologies Corp. (ADPT)
26.26
+0.71
(+2.78%)
USD |
NASDAQ |
Aug 25, 13:49
Adaptive Biotechnologies Total Return Level : 25.55 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 25.55 |
| August 21, 2026 | 25.99 |
| August 20, 2026 | 25.44 |
| August 19, 2026 | 25.49 |
| August 18, 2026 | 24.56 |
| August 17, 2026 | 24.77 |
| August 14, 2026 | 24.74 |
| August 13, 2026 | 24.46 |
| August 12, 2026 | 25.25 |
| August 11, 2026 | 25.39 |
| August 10, 2026 | 25.45 |
| August 07, 2026 | 24.93 |
| August 06, 2026 | 23.60 |
| August 05, 2026 | 24.60 |
| August 04, 2026 | 24.55 |
| August 03, 2026 | 23.11 |
| July 31, 2026 | 22.57 |
| July 30, 2026 | 24.18 |
| July 29, 2026 | 22.56 |
| July 28, 2026 | 22.52 |
| July 27, 2026 | 22.54 |
| July 24, 2026 | 22.27 |
| July 23, 2026 | 22.31 |
| July 22, 2026 | 21.95 |
| July 21, 2026 | 22.58 |
| Date | Value |
|---|---|
| July 20, 2026 | 21.86 |
| July 17, 2026 | 22.92 |
| July 16, 2026 | 22.10 |
| July 15, 2026 | 22.90 |
| July 14, 2026 | 21.43 |
| July 13, 2026 | 21.02 |
| July 10, 2026 | 21.06 |
| July 09, 2026 | 21.80 |
| July 08, 2026 | 20.16 |
| July 07, 2026 | 20.82 |
| July 06, 2026 | 21.50 |
| July 02, 2026 | 21.19 |
| July 01, 2026 | 22.37 |
| June 30, 2026 | 21.45 |
| June 29, 2026 | 21.40 |
| June 26, 2026 | 20.96 |
| June 25, 2026 | 20.25 |
| June 24, 2026 | 19.34 |
| June 23, 2026 | 17.23 |
| June 22, 2026 | 17.37 |
| June 18, 2026 | 17.53 |
| June 17, 2026 | 16.78 |
| June 16, 2026 | 17.22 |
| June 15, 2026 | 17.46 |
| June 12, 2026 | 17.60 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Personalis, Inc. | 17.06 |
| 10X Genomics, Inc. | 63.80 |
| Alamar Biosciences, Inc. (California) | 32.70 |
| Champions Oncology, Inc. | 4.97 |
| Medpace Holdings, Inc. | 620.03 |